Jamie Teo
reacted to
Heres a few stocks to put you in the race to the top: Safest to riskiest
$Molecular (MOLN.US)$ Has already touched its support. Just building up volume until it can run to 12.00.
$Surrozen (SRZN.US)$ Building up volume also to make a run to a new high.
$Autonomix Medical (AMIX.US)$ As soon as it finds bottom it will make a big run. Has lockup expiring with an 85% short interest rate. Those are two big green flags.
$SYLA Technologies (SYT.US)$ Back at its bottom. Will build up...
$Molecular (MOLN.US)$ Has already touched its support. Just building up volume until it can run to 12.00.
$Surrozen (SRZN.US)$ Building up volume also to make a run to a new high.
$Autonomix Medical (AMIX.US)$ As soon as it finds bottom it will make a big run. Has lockup expiring with an 85% short interest rate. Those are two big green flags.
$SYLA Technologies (SYT.US)$ Back at its bottom. Will build up...
15
4
1
Jamie Teo
commented on
$SEALSQ Corp (LAES.US)$ How much is the night trading now
Translated
6
Jamie Teo
liked and commented on
2
10
Jamie Teo
reacted to
$Color Star Technology (ADD.US)$ Is there still hope? I'm at 3+
Translated
6
1
Jamie Teo
liked
$Phio Pharmaceuticals (PHIO.US)$ 😭 I keep picking the wrong pharma companies.
2
4
Jamie Teo
reacted to
$Snow Lake Resources (LITM.US)$
Gallium is a critical element used in electronics, including military technology.
China has the most supply of this element and exports 98% of the world’s gallium need. Hence, this discovery is of a huge importance to lessen the dominance of China in this aspect.
Gallium is a critical element used in electronics, including military technology.
China has the most supply of this element and exports 98% of the world’s gallium need. Hence, this discovery is of a huge importance to lessen the dominance of China in this aspect.
9
13
Jamie Teo
reacted to
15
2
Jamie Teo
liked
$Phio Pharmaceuticals (PHIO.US)$
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762
Monday, 13th January at 7:45 am
Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma
Marlborough, Massachusetts--(Newsfile Corp. - January 13, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology de...
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762
Monday, 13th January at 7:45 am
Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma
Marlborough, Massachusetts--(Newsfile Corp. - January 13, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology de...
1